Multivariate explanatory model for sporadic carcinoma of the colon in Dukes' stages I and IIa

International Journal of Medical Sciences

Volumn 6, Issue 1, 2009, Pages 43-50

  Villadiego Sanchez J M ^a   Ortega Calvo, M ^b,e   Pino Mejias R ^c   Cayuela, A ^d   Iglesias Bonilla, P ^b   Garcia de La Corte F ^b   Santos Lozano, J M ^b   Lapetra Peralta, José ^b  

^a 061 Accident and Emergency Service   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e NONE   (Spain)

Author keywords

Multivariate explanatory model; Non paired case control study; Sporadic carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; CA 19-9 ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CANCER STAGING; COLON CARCINOMA; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; SPAIN; VALIDATION PROCESS;

EID: 60149095567     PISSN: None     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.6.43     Document Type: Article

References (39)

1. Rose G, Blackburn H, Keys A, et al. Colon cancer and blood cholesterol. Lancet 1974; 1: 181-3.
2. Law M.R., Thompson S.G. Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies. Cancer Causes Control. 1991; 2:253-261.
3. Kritchevsky S.B., Kritchevsky D. Serum cholesterol and cancer risk: An epidemiologic perspective. Annu. Rev. Nutr. 1992;12:391-416.
4. Kono S., Ikeda H., Yanai F., Yamamoto M., Shigematsu T. Serum lipids and colorectal adenoma among male self-defence officials in northern Kyushu, Japan. International Journal of Epidemiology 1990; 19:274-278.
5. Winawer SJ., Flehinger BJ., Buchalter J., Herbert E., Shike M. Declining serum cholesterol levels prior to diagnosis of colon cancer. A time - trend, case - control study. JAMA. 1990; 263:2083-2085.
6. Fernandez Bañares F., Esteve M., Navarro E, Cabre E., Boix J., Abad Lacruz A, et al. Changes of the mucosal n3 and n6 fatty acid status occur early in the colorectal adenoma-carcinoma sequence. Gut. 1996; 38:254-259.
7. Törnberg S.A., Holm L.E., Carstensen J.M., Eklund G.A. Risk of cancer of the colon and rectum in relation to serum cholesterol and beta-lipoprotein. N.Engl.J.Med. 1986;315:1629-1633.
8. Yamada K., Araki S., Tamura M., Sakai I., Takahashi Y., Kashihara H., Kono S. Relation of serum total cholesterol, serum triglycerides and fasting plasma glucose to colorectal carcinoma in situ. International Journal of Epidemiology. 1998;27:794-798.
9. Jacobs D., Blackburn H., Higgins M., Redd D., Iso H, MacMillan G, et al. Report of the Conference on Low Blood Cholesterol: Mortality associations. Circulation. 1992; 86: 1046-1060.
10. Park SK, Joo JS, Kim DH, Kim YE, Kang D, Yoo KY: Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case-control study in Korea. J Korean Med Sci 2000;15: 690-695.
11. Eichholzer M., Stahelin HB., Gutzwiller F., Ludin E., Bernasconi F. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-years follow-up of the prospective Basel study. Am J Clin Nutr.2000; 71: 569-574.
12. Shor R, Wainstein J, Oz D, Boaz M, Matas Z, Fux A, Halabe A. Low HDL levels and the risk of death, sepsis and malignancy. Clin Res Cardiol. 2008;97:227-233.
13. Sugarbaker P.H. Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer. Ann. Surg. 1976; 184: 752-757.
14. Yuste A.L., Aparicio J., Segura A., López-Tendero P., Girones R., Pérez Fidalgo J.A., Díaz R., Calderero V. Analysis of clinical prognostic factors for survival and time to progression in patient with metastatic colorectal cancer treated with 5-fluoroucil-based chemotherapy. Clin Colorrectal Cancer. 2003; 4: 231-234.
15. Sanz Rubiales A., García Alvarez G. Significance of carcinoembryonic antigen in the follow up of colorectal cancer. Medicina Clínica (Barcelona).1998; 110: 277-278.
16. Bannura G, Cumsille MA, Contreras J, Barrera A, Melo C, Soto D: Carcinoembryonic antigen (CEA) as an independent prognostic factor in colorectal carcinoma. Rev Méd Chile 2004; 132: 691-700.
17. Filella X., Molina R., Piqué J.M., García-Valdecasas J.C., Grau J.J., Novell F, et al. Use of Ca 19.9 in the early detection of recurrences in colorectal cancer: comparison with CEA. Tumor Biology. 1994; 15:1-6.
18. Mendez Mora J.L., Ortega Calvo M., Cayuela Dominguez A., Villadiego Sanchez J.M., Barros Pérez M.M., Cantillana Martinez J. CA 19.9 and HDL-cholesterol behaviour in a sporadic colorectal carcinoma sample. An Med Interna (Madrid). 2004; 21: 227-230.
19. Moran J.L., Solomon P. Worrying about normality. Critical Care and Resuscitation. 2002, 4: 316-319.
20. Sánchez-Cantalejo Ramírez E. Regresión Logística en Salud Pública (Serie Monografías no 26). Granada: Escuela Andaluza de Salud Pública. 2000
21. Ortega-Calvo M., Cayuela-Dominguez A. Unconditioned logistic regression and sample size: a bibliographic review. Rev.Esp.Salud Publica. 2002; 76:85-93.
22. Justice,A.C., Covinsky,K.E..,Berlin,J.A. Assessing the generalizability of prognostic information. Ann. Intern. Med. 1999; 130: 515-524.
23. Feinstein AR, Walter SD, Horwitz RI. An analysis of Berkson's bias in case-control studies. J Chronic Dis. 1986; 39: 495-504.
24. Delgado-Rodriguez M, Llorca J: Bias. J Epidemiol Community Health. 2004;58: 635-641.
25. Efron B. Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods. Biometrika.1981; 68:589-599.
26. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall 1993.
27. Varol E, Ozaydin M, Dogan A, Kosar F: Tumour marker levels in patients with chronic heart failure. Eur J Heart Fail. 2005;7:840-843.
28. Carpelan-Holmstrom M, Louhimo J, Stenman UH, Alfthan H, Jarvinen H, Haglund C. Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology. 2004;66:296-302.
29. Notarnicola M, Altomare DF, Correale M, Ruggieri E, D'Attoma B, Mastrosimini A, Guerra V, Caruso MG. Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases. Oncology. 2005;68: 371-374.
30. Astler V.B., Coller F.A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954;139: 846-852
31. Caruso MG, Notarnicola M. Biochemical changes of mevalonate pathway in human colorectal cancer. Anticancer Res. 2005;25:3393-3397.
32. Shah BR, Laupacis A, Hux JE, Austin PC: Propensity score methods gave similar results to traditional regression modeling in observational studies: a systematic review. J Clin Epidemiol. 2005; 58: 550-559.
33. Song JH, Venkatesh SS, Conant EA, Arger PH, Sehgal CM. Comparative analysis of logistic regression and artificial neural network for computer-aided diagnosis of breast masses. Acad Radiol. 2005;12:487-495.
34. Austin PC, Tu JV: Automated variable selection methods for logistic regression produced unstable models for predicting acute myocardial infarction mortality. J Clin Epidemiol. 2004;57:1138-1146.
35. nd edition. Philadelphia: Lippincot Williams & Wilkins. 1998:385-386.
36. Altman DG, Andersen PK. Bootstrap investigation of the stability of a Cox regression model. Statistics in Medicine 1989;8:771-783.
37. Macchia V, Gargiulo M, Terracciano D, Di Carlo A, Mariano A. Cyclic AMP - dependent secretion of Ca 19-9 by LS174T human colon carcinoma cells. Oncol Rep. 2002; 9: 387-391.
38. Terracciano D, Mariano A, Macchia V, Di Carlo A: Analysis of glycoproteins in human colon cancers, normal tissues and in human colon carcinoma cells reactive with monoclonal antibody NCL-19-9. Oncol Rep. 2005; 14:719-722.
39. Nozoe T, Rikimaru T, Mori E, Okuyama T, Takahashi I. Increase in both CEA and CA19-9 in sera is an independent prognostic indicator in colorectal carcinoma. J Surg Oncol. 2006; 94: 132-137.